Full-Time

Oncology Nurse

Posted on 11/14/2025

Akumin

Akumin

1,001-5,000 employees

Outsourced radiology and oncology services

No salary listed

Reno, NV, USA

In Person

Category
Medical, Clinical & Veterinary (1)
Requirements
  • Associate's Degree or Equivalent Experience.
  • RN License.
  • CPR Certification.
  • State drivers’ license.
  • Local travel may be required.
  • The COVID-19 vaccination is/may be a condition of employment.
Responsibilities
  • Demonstrates ongoing nursing assessments to include: assessing patients for therapy side effects and providing appropriate nursing interventions. May be required to perform laboratory functions such as blood/specimen collection.
  • Educates patients and family members regarding their specific diagnosis, treatment and management of side effects. Provides emotional support to patients and families and makes appropriate referrals to community and hospital support services, such as social work, home care, hospice, etc., as needed. This would include coordinating hospital admissions.
  • Assists in coordinating the scheduling of patient consultations, simulations and follow-up visits. Assists with scheduling of required outpatient lab tests, x-rays, and scans as needed.
  • Works with the oncologist on all patient care, follow-up, and medical management. Assists physicians during patient exams and procedures performed in the department.
  • Maintains comprehensive and accurate records of all patient activities, including exams, diagnostic testing, medications, cancer treatments, referring physician information, etc.
  • Oversees the maintenance and care of examination equipment and supplies including maintaining stock levels of supplies and materials, checking for outdates, and ensuring center exam room and equipment is in good working order.
  • Coordinates and directs center support groups and screening efforts.
  • Abides by departmental policies and procedures to include infection control, blood borne pathogens, precautions, radiation safety, privacy and HIPAA. Appropriately refers questions, requests or problems to supervisors.
Desired Qualifications
  • Certificate from College or Technical School.
  • 2 yrs. oncology nursing experience.

Akumin provides outsourced radiology and oncology services to hospitals, health systems, and physician groups across the United States through a network of fixed-site outpatient imaging centers and outpatient radiology and oncology services. It operates imaging centers and partners with healthcare facilities to offer diagnostic imaging, interpretation, and related outpatient services at scale across 47 states. Its nationwide focus on outsourced radiology and oncology allows hospitals to access imaging and cancer-care resources without maintaining all services in-house. The company aims to be a trusted partner for healthcare providers by delivering reliable, scalable imaging and cancer-care services that improve patient access to diagnostics and treatment.

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

Plantation, Florida

Founded

1997

Simplify Jobs

Simplify's Take

What believers are saying

  • Stonepeak invests $154M for long-term growth capital.
  • Debt restructures to new notes due 2031 at 8.75-9.75%.
  • Private equity drives steady diagnostic imaging deals in 2025.

What critics are saying

  • RadNet acquisitions capture Akumin's MRI market share.
  • Stonepeak strips assets post-privatization in 18-36 months.
  • Alliance HealthCare poaches radiation oncology referrals.

What makes Akumin unique

  • Akumin AXIS Drop Trailer expands mobile imaging capabilities.
  • Relocatable MRI suites launched at RSNA meeting.
  • National network offers outpatient imaging and radiation therapy.

Help us improve and share your feedback! Did you find this helpful?

Your Connections

People at Akumin who can refer or advise you

Benefits

Flexible Work Hours

Growth & Insights and Company News

Headcount

6 month growth

-12%

1 year growth

-12%

2 year growth

-12%
Innovate Healthcare
Jan 5th, 2026
Akumin secures $154M investment and restructures debt to extend repayment timeline to 2031

Akumin Inc. has secured $154 million in new capital from Stonepeak, an alternative investment firm, to support long-term growth of its imaging and radiation oncology services. The company is also restructuring its debt with noteholders representing over 95% of its outstanding senior secured notes. Under the agreement, Akumin's existing debt will be exchanged for new senior secured notes due in 2031, carrying a 9.75% interest rate that can drop to 8.75% if certain credit targets are met. The company's revolving credit facility, with roughly $119 million outstanding, will convert into preferred equity or move to a lower-priority position. The restructuring follows Akumin's recent launch of new offerings at the Radiological Society of North America meeting, including its Axis Drop Trailer and relocatable MRI suites.

Cantech Letter
Oct 23rd, 2023
Akumin likely won’t get a better offer than Stonepeak, Clarus says

The deal from private equity firm Stonepeak to acquire Akumin likely won’t be topped, says Clarus Securities analyst Noel Atkinson.

PR Newswire
Oct 20th, 2023
Akumin Inc. Reaches Agreement With Stonepeak To Become A Private Company

Financial restructuring to fortify balance sheet and provide liquidity runway for next stage of growthApprovals received from key stakeholders across capital structure; transaction will be implemented through prepackaged court-supervised process; Expected to obtain court approval within the next 45 daysBusiness will continue to operate as usual without interruption; trade creditors, employees, and other partners expected to continue to be paid in ordinary coursePLANTATION, Fla., Oct. 20, 2023 /PRNewswire/ - Akumin Inc. ("Akumin" or the "Company") (NASDAQ: AKU) (TSX: AKU) announced today that it has reached an agreement with Stonepeak, a leading alternative investment firm specializing in infrastructure and real assets, and the Company's stakeholders on the terms of a financial restructuring that will substantially improve the Company's balance sheet and provide ample liquidity to position Akumin for future success. The contemplated transaction will result in Akumin no longer being publicly listed.To effect the transaction in a timely and efficient manner, the Company and certain of its subsidiaries will commence prepackaged chapter 11 cases in the Southern District of Texas. The Company expects to obtain court approval of the transaction within the next 45 days and complete the transaction after receiving certain regulatory approvals. Throughout the process, Akumin's operations are expected to continue as normal

INACTIVE